6B1G image
Deposition Date 2017-09-18
Release Date 2018-02-28
Last Version Date 2024-05-01
Entry Detail
PDB ID:
6B1G
Title:
Solution structure of TDP-43 N-terminal domain dimer.
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
200
Conformers Submitted:
20
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:TAR DNA-binding protein 43, S48E Mutant
Gene (Uniprot):TARDBP
Mutagens:S48E
Chain IDs:A
Chain Length:83
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:TAR DNA-binding protein 43, Y4R Mutant
Gene (Uniprot):TARDBP
Mutagens:Y4R
Chain IDs:B
Chain Length:83
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing.
EMBO J. 37 ? ? (2018)
PMID: 29438978 DOI: 10.15252/embj.201797452

Abstact

TDP-43 is an RNA-binding protein active in splicing that concentrates into membraneless ribonucleoprotein granules and forms aggregates in amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. Although best known for its predominantly disordered C-terminal domain which mediates ALS inclusions, TDP-43 has a globular N-terminal domain (NTD). Here, we show that TDP-43 NTD assembles into head-to-tail linear chains and that phosphomimetic substitution at S48 disrupts TDP-43 polymeric assembly, discourages liquid-liquid phase separation (LLPS) in vitro, fluidizes liquid-liquid phase separated nuclear TDP-43 reporter constructs in cells, and disrupts RNA splicing activity. Finally, we present the solution NMR structure of a head-to-tail NTD dimer comprised of two engineered variants that allow saturation of the native polymerization interface while disrupting higher-order polymerization. These data provide structural detail for the established mechanistic role of the well-folded TDP-43 NTD in splicing and link this function to LLPS. In addition, the fusion-tag solubilized, recombinant form of TDP-43 full-length protein developed here will enable future phase separation and in vitro biochemical assays on TDP-43 function and interactions that have been hampered in the past by TDP-43 aggregation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures